Wataru Takeuchi

Wataru Takeuchi

Auto-generated profile, based on publicly available information

Wataru Takeuchi

Center for Technology Innovation–Artificial Intelligence, Research & Development Group Hitachi, Ltd Tokyo Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2021 in JMIR Medical Informatics
Verified
Journal Article
Open access
SMSHIGEO MURO
SHIGEO MURO
MIMasato Ishida
Masato Ishida
YHYoshiharu Horie
Yoshiharu Horie
WTWataru Takeuchi
Wataru Takeuchi
SNShunki Nakagawa
Shunki Nakagawa
Tetsuhisa KitamuraTetsuhisa Kitamura
Tetsuhisa Kitamura
Background: Airflow limitation is a critical physiological feature in chronic obstructive pulmonary disease (COPD), for which long-term exposure to noxious substances, including tobacco smoke, is an established risk. However, not all long-term smokers develop COPD, meaning that other risk factors exist. Objective: This study aimed to predict the risk factors for COPD diagnosis using machine learning in an annual medical check-up database. Methods: In this retrospective observational cohort study (ARTDECO [Analysis of Risk Factors to Detect COPD]), annual medical check-up records for all Hitachi Ltd employees in Japan collected from April 1998 to March 2019 were analyzed. Employees who provided informed consent via an opt-out model were screened and those aged 30 to 75 years without a prior diagnosis of COPD/asthma or a history of cancer were included. The database included clinical measurements (eg, pulmonary function tests) and questionnaire responses. To predict the risk factors for COPD diagnosis within a 3-year period, the Gradient Boosting Decision Tree machine learning (XGBoost) method was applied as a primary approach, with logistic regression as a secondary method. A diagnosis of COPD was made when the ratio of the prebronchodilator forced expiratory volume in 1 second (FEV1) to prebronchodilator forced vital capacity (FVC) was <0.7 during two consecutive examinations. Results: Of the 26,101 individuals screened, 1213 met the exclusion criteria, and thus, 24,815 individuals were included in the analysis. The top 10 predictors for COPD diagnosis were FEV1/FVC, smoking status, allergic symptoms, cough, pack years, hemoglobin A1c, serum albumin, mean corpuscular volume, percent predicted vital capacity, and percent predicted value of FEV1. The areas under the receiver operating characteristic curves of the XGBoost model and the logistic regression model were 0.956 and 0.943, respectively. Conclusions: Using a machine learning model in this longitudinal database, we identified a number of parameters as risk factors other than smoking exposure or lung function to support general practitioners and occupational health physicians to predict the development of COPD. Further research to confirm our results is warranted, as our analysis involved a database used only in Japan.

1 January 2016 in Internal Medicine
Verified
Journal Article
Open access
YWYasushi Wakabayashi
Yasushi Wakabayashi
MIMai Iwaya
Mai Iwaya
MAMayo Akita
Mayo Akita
WTWataru Takeuchi
Wataru Takeuchi
KYKyohei Yamazaki
Kyohei Yamazaki
AIAkihiro Iijima
Akihiro Iijima
Pulmonary tumor thrombotic microangiopathy (PTTM) is a fatal cancer-related pulmonary complication. It is generally caused by gastric adenocarcinoma, and several molecules produced by tumor cells are reported to play important roles in its pathogenesis. We herein report an autopsy case of PTTM caused by urothelial carcinoma. Vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and osteopontin were found to be expressed in both the primary tumor cells and metastatic cells in the PTTM lesions. These findings implicate the possible involvement of VEGF, PDGF, and osteopontin in the pathogenesis of PTTM caused by urothelial carcinoma.

22 February 2021 in Clinical and Experimental Neuroimmunology
Verified
Journal Article
Closed access
PDF file
WTWataru Takeuchi
Wataru Takeuchi
JFJuichi Fujimori
Juichi Fujimori
INIchiro Nakashima
Ichiro Nakashima

5 October 2020 in JMIR Preprints
Verified
Preprint
Open access
SMSHIGEO MURO
SHIGEO MURO
MIMasato Ishida
Masato Ishida
YHYoshiharu Horie
Yoshiharu Horie
WTWataru Takeuchi
Wataru Takeuchi
SNShunki Nakagawa
Shunki Nakagawa
Tetsuhisa KitamuraTetsuhisa Kitamura
Tetsuhisa Kitamura
BACKGROUND Airflow limitation is a critical physiological feature in chronic obstructive pulmonary disease (COPD), for which long-term exposure to noxious substances, including tobacco smoke, is an established risk. However, not all long-term smokers develop COPD, meaning that other risk factors exist. OBJECTIVE This study aimed to predict the risk factors for COPD diagnosis using machine learning in an annual medical check-up database. METHODS In this retrospective observational cohort study (ARTDECO [Analysis of Risk Factors to Detect COPD]), annual medical check-up records for all Hitachi Ltd employees in Japan collected from April 1998 to March 2019 were analyzed. Employees who provided informed consent via an opt-out model were screened and those aged 30 to 75 years without a prior diagnosis of COPD/asthma or a history of cancer were included. The database included clinical measurements (eg, pulmonary function tests) and questionnaire responses. To predict the risk factors for COPD diagnosis within a 3-year period, the Gradient Boosting Decision Tree machine learning (XGBoost) method was applied as a primary approach, with logistic regression as a secondary method. A diagnosis of COPD was made when the ratio of the prebronchodilator forced expiratory volume in 1 second (FEV1) to prebronchodilator forced vital capacity (FVC) was <0.7 during two consecutive examinations. RESULTS Of the 26,101 individuals screened, 1213 met the exclusion criteria, and thus, 24,815 individuals were included in the analysis. The top 10 predictors for COPD diagnosis were FEV1/FVC, smoking status, allergic symptoms, cough, pack years, hemoglobin A1c, serum albumin, mean corpuscular volume, percent predicted vital capacity, and percent predicted value of FEV1. The areas under the receiver operating characteristic curves of the XGBoost model and the logistic regression model were 0.956 and 0.943, respectively. CONCLUSIONS Using a machine learning model in this longitudinal database, we identified a number of parameters as risk factors other than smoking exposure or lung function to support general practitioners and occupational health physicians to predict the development of COPD. Further research to confirm our results is warranted, as our analysis involved a database used only in Japan.